165 related articles for article (PubMed ID: 28072616)
1. Gastrointestinal Stromal Tumor Showing Intense Tracer Uptake on PSMA PET/CT.
Noto B; Weckesser M; Buerke B; Pixberg M; Avramovic N
Clin Nucl Med; 2017 Mar; 42(3):200-202. PubMed ID: 28072616
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-Prostate-Specific Membrane Antigen Uptake in Gastrointestinal Stromal Tumor.
Laurens ST; Witjes F; Janssen M; Flucke U; Gottardt M
Clin Nucl Med; 2018 Jan; 43(1):60-61. PubMed ID: 29166327
[TBL] [Abstract][Full Text] [Related]
3. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Early dynamic imaging in
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
[TBL] [Abstract][Full Text] [Related]
6. Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [
Berliner C; Tienken M; Frenzel T; Kobayashi Y; Helberg A; Kirchner U; Klutmann S; Beyersdorff D; Budäus L; Wester HJ; Mester J; Bannas P
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):670-677. PubMed ID: 27896369
[TBL] [Abstract][Full Text] [Related]
7. 68Ga-PSMA Uptake in an Incidentally Detected Gastrointestinal Stromal Tumor in a Case of Suspected Carcinoma Prostate.
Sasikumar A; Joy A; Pillai M; S B; Sr S
Clin Nucl Med; 2017 Oct; 42(10):e447-e448. PubMed ID: 28759526
[TBL] [Abstract][Full Text] [Related]
8. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
Chan M; Hsiao E
Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
[TBL] [Abstract][Full Text] [Related]
10.
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
[TBL] [Abstract][Full Text] [Related]
11. Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT.
Kanthan GL; Izard MA; Emmett L; Hsiao E; Schembri GP
Clin Nucl Med; 2016 Sep; 41(9):703-4. PubMed ID: 27405039
[TBL] [Abstract][Full Text] [Related]
12. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
[TBL] [Abstract][Full Text] [Related]
13. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
Bhardwaj H; Stephens M; Bhatt M; Thomas PA
Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
[TBL] [Abstract][Full Text] [Related]
14. PSA levels, PSA doubling time, Gleason score and prior therapy cannot predict measured uptake of [68Ga]PSMA-HBED-CC lesion uptake in recurrent/metastatic prostate cancer.
Verburg FA; Pfister D; Drude NI; Mottaghy FM; Behrendt FF
Nuklearmedizin; 2017; 56(6):225-232. PubMed ID: 29044297
[TBL] [Abstract][Full Text] [Related]
15. Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT.
Kanthan GL; Hsiao E; Kneebone A; Eade T; Schembri GP
Clin Nucl Med; 2016 Jun; 41(6):508-9. PubMed ID: 26909712
[TBL] [Abstract][Full Text] [Related]
16. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer.
Fendler WP; Schmidt DF; Wenter V; Thierfelder KM; Zach C; Stief C; Bartenstein P; Kirchner T; Gildehaus FJ; Gratzke C; Faber C
J Nucl Med; 2016 Nov; 57(11):1720-1725. PubMed ID: 27261520
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
19. The reconstruction algorithm used for [
Krohn T; Birmes A; Winz OH; Drude NI; Mottaghy FM; Behrendt FF; Verburg FA
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):662-669. PubMed ID: 27900518
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A; Avtzi E; Giesel FL; Holland-Letz T; Linhart HG; Eder M; Eisenhut M; Boxler S; Hadaschik BA; Kratochwil C; Weichert W; Kopka K; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):197-209. PubMed ID: 25411132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]